Literature DB >> 32312222

Association Between Atrial Fibrillation and Cognitive Impairment in Individuals With Prior Stroke: A Meta-Analysis and Meta-Regression Analysis.

Damianos G Kokkinidis1, Nikos Zareifopoulos2,3, Christina A Theochari4, Angelos Arfaras-Melainis1, Christos A Papanastasiou5, Dipan Uppal1, George Giannakoulas5, Andreas P Kalogeropoulos6, Joao Daniel T Fontes7.   

Abstract

Background and Purpose- Atrial fibrillation (AF) is the most common chronic arrhythmia. Dementia and cognitive impairment (CI) are major burdens to public health. The prevalence of all 3 entities is projected to increase due to population aging. Previous reports have linked AF with a higher risk of CI and dementia in patients without prior stroke. Stroke is known to increase the risk for dementia and CI. It is unclear if AF in patients with history of stroke can further increase the risk for dementia or CI. Our purpose was to evaluate the impact of AF on risk for dementia or CI among patients with history of stroke. Methods- Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines were followed. Pubmed, Scopus, and Cochrane central were searched. The outcomes of interest were dementia, CI, and the composite end point of dementia or CI. A random-effect model meta-analysis was performed. Meta-regression analysis was also performed. Publication bias was assessed with the Egger test and with funnel plots. Results- Fourteen studies and 14 360 patients (1363 with AF) were included in the meta-analysis. In the meta-analysis of adjusted odds ratio, AF was associated with increased risk of CI (odds ratio, 1.60 [95% CI, 1.20-2.14]), dementia (odds ratio, 3.11 [95% CI, 2.05-4.73]), and the composite end point of CI or dementia (odds ratio, 2.26 [95% CI, 1.61-3.19]). The heterogeneity for the composite end point of dementia or CI was moderate (adjusted analysis). The heterogeneity for the analysis of the end point of CI only was substantial in the unadjusted analysis and moderate in the adjusted analysis. The heterogeneity for the end point of dementia only was moderate in the unadjusted analysis and zero in the adjusted analysis. Conclusions- Our results indicate that an association between AF and CI or dementia is patients with prior strokes is possible given the persistent positive associations we noticed in the unadjusted and adjusted analyses. The heterogeneity levels limit the certainty of our findings.

Entities:  

Keywords:  atrial fibrillation; dementia; meta-analysis; population; prevalence

Year:  2020        PMID: 32312222     DOI: 10.1161/STROKEAHA.119.027815

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

1.  The Relationship Between Vitamin D and Postoperative Atrial Fibrillation: A Prospective Cohort Study.

Authors:  Amelie H Ohlrogge; Jan Brederecke; Francisco M Ojeda; Simon Pecha; Christin S Börschel; Lenard Conradi; Vanessa Rimkus; Stefan Blankenberg; Tanja Zeller; Renate B Schnabel
Journal:  Front Nutr       Date:  2022-05-10

Review 2.  Genetic Variants behind Cardiovascular Diseases and Dementia.

Authors:  Wei-Min Ho; Yah-Yuan Wu; Yi-Chun Chen
Journal:  Genes (Basel)       Date:  2020-12-18       Impact factor: 4.096

3.  Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis.

Authors:  Wei-Jia Li; Paraschos Archontakis-Barakakis; Leonidas Palaiodimos; Dimitrios Kalaitzoglou; Lazaros Tzelves; Apostolos Manolopoulos; Yu-Chiang Wang; Stefanos Giannopoulos; Robert Faillace; Damianos G Kokkinidis
Journal:  World J Cardiol       Date:  2021-04-26

4.  Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer's Disease: a Systematic Review and Meta-Analysis.

Authors:  Christos A Papanastasiou; Christina A Theochari; Nikos Zareifopoulos; Angelos Arfaras-Melainis; George Giannakoulas; Theodoros D Karamitsos; Leonidas Palaiodimos; George Ntaios; Konstantinos I Avgerinos; Dimitrios Kapogiannis; Damianos G Kokkinidis
Journal:  J Gen Intern Med       Date:  2021-07-09       Impact factor: 6.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.